Far-UV Sterilray™ from Ocular PhotoDisinfection, LLC provides a collimated beam of 222nm Far-UV Sterilray™ light to tissue or instruments to sterilize the tissue from all known microbial organisms. The primary medical issue that the Far-UV Sterilray™ addresses is ophthalmic infectious disease. Extant antibiotics are meeting increasing microbial resistance. Practicing ophthalmologists, optometrists and physicians as primary care providers confront infectious eye disease on a daily basis. Although many third and fourth generation fluoroquiolones are active against these infections, the time delay in speciating the infectious organisms confounds the prescription of appropriate antibiotics. Corneal ulcers caused by fungi, acanthamoeba and viruses all require precise, but different antibiotic classes. The Far-UV Sterilray™ device provides immediate killing power of all known microbial organisms, while sparing the mammalian tissue cells from injury. The killing power of this solitary wavelength against bacteria, fungi, parasites, cysts and viruses makes it a powerful tool for sterilizing donor corneal tissue before distribution and against corneal and conjunctival infections. Recent testing has proven the safety of the 222 nm Far-UV Sterilray™ wavelength on corneal endothelial cells, by specular microscopy up to seven days post Far-UV Sterilray™ exposure. In addition, we have independently demonstrated the killing power of this wavelength against Staph aureus, Psedomonas aeruginosa and Candida albicans, while sparing corneal tissue.

• Ocular PhotoDisinfection LLC is an early-stage disinfection device manufacturer in Dover NH.
• Ocular PD is licensed to sell devices based on patented Far-UV Sterilray™ Technology exclusively to the Ophthalmology Sector from the holder of the patents SEdward Neister-Pathogen Path Consultants LLC.
• The Company is seeking to commercialize its first ocular device.
• It has 3 commercialized disinfection devices now for sale.